Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis

Patients with kidney failure have notoriously weak responses to common vaccines. Thus, immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine immunogenicity of SARS-CoV-2 vaccination in patients with chronic dialysis, we analyzed the humoral and T-cell response aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrezenmeier, Eva, Bergfeld, Leon, Hillus, David, Lippert, Joerg-Detlev, Weber, Ulrike, Tober-Lau, Pinkus, Landgraf, Irmgard, Schwarz, Tatjana, Kappert, Kai, Stefanski, Ana-Luisa, Sattler, Arne, Kotsch, Katja, Dörner, Thomas, Sander, Leif Erik, Budde, Klemens, Halleck, Fabian, Kurth, Florian, Corman, Victor Max, Choi, Mira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284337/
https://www.ncbi.nlm.nih.gov/pubmed/34276681
http://dx.doi.org/10.3389/fimmu.2021.690698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284337/
https://www.ncbi.nlm.nih.gov/pubmed/34276681
http://dx.doi.org/10.3389/fimmu.2021.690698

Ejemplares similares